Research Nester published a report titled “Opioid Dependence Treatment Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of theglobalopioid dependence treatment market in terms of market segmentation by drug class, sales channel, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global opioid dependence treatment market is estimated to occupy a sizeable revenue by growing at a significant CAGR during the forecast period, i.e., 2022 – 2031, ascribing to the growing cases of opioid abuse and addiction amongst people across the globe, and availability of favorable reimbursements for smoking cessation therapy. Along with these, escalating investments by pharmaceutical companies for introducing new products to treat opioid dependence, and increasing number of rehabilitation treatment clinics worldwide are also expected to drive the growth of the market in the forthcoming years.
The market is segmented by drug class and sales channel. Based on drug class, the buprenorphine segment is anticipated to occupy the largest share during the forecast period in view of the rising growing utilization of buprenorphine patches for the treatment of opioid use disorder, as a result of their properties such as self-administrability and reduction in pain. Additionally, by sales channel, the hospitals segment is projected to acquire the largest share over the forecast period attributing to the high dependence of patients on hospital settings for the administration of parenteral drugs.
Geographically, the global opioid dependence treatment market is segmented into five major regions, namely North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. North America is evaluated to gather the largest share in the market during the forecast period attributing to the high health expenditure, and rising prevalence of opioid dependency disorder in the region. Moreover, the market in Asia Pacific is assessed to observe noteworthy growth over the forecast period on the back of the upsurge in awareness among general population about opioid use disorder, and large number of patients in the region.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Rising Number of Cases of Opioid Abuse Among People Globally to Drive Market Growth
Over the last two decades, the total number of incidences of opioid abuse and addiction has witnessed a notable upsurge. Changes in the lifestyle habits of people, along with growing usage of opioids for pain management can be credited as the major reasons for the same. This in turn is anticipated to drive market growth significantly in the near future.
However, adverse effects of opioid use disorder drugs are expected to operate as key restraints to the growth of the global opioid dependence treatment market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global opioid dependence treatment market which includes company profiling of Orexo AB, Indivior PLC, Titan Pharmaceuticals, Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, BioDelivery Sciences International Inc., Teva Pharmaceutical Industries Ltd., Alkermes, Camurus AB, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global opioid dependence treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/opioid-dependence-treatment-market/4003
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.